GlcNAcβ(1-3)[Neu5Acα(2-6)]GalNAc-α-pNP
|
|
1858223-99-0
|
β-Glc-PEG3-Azide
|
|
156058-83-2
|
Gastrin II Sulfated
|
|
19361-51-4
|
Glutaryl-L-carnitine lithium salt
|
|
102636-82-8
|
GW8510
|
|
222036-17-1
|
Gadolinium
|
|
7440-54-2
|
4-Glycidyloxy-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical
|
|
122413-85-8
|
Guanosine-3′,5′-cyclic Monophosphate, 8-(2-Aminophenylthio)-Sodium Salt
|
|
144509-87-5
|
GSK-3 Inhibitor II
|
|
478482-75-6
|
Gadobutrol Monohydrate
|
|
198637-52-4
|
GSK-F1
|
|
1402345-92-9
|
Glycerol trihexanoate
|
|
621-70-5
|
Guanidine hydrochloride
|
|
50-01-1
|
Gibberellins A4/A7
|
|
8030-53-3
|
Gentiobiosyloleandrin
|
|
53270-25-0
|
Gitoxin
|
|
4562-36-1
|
GSK-3 Inhibitor X
|
|
740841-15-0
|
Glyceryl trioctanoate
|
|
538-23-8
|
Ganoderic Acid B
|
|
81907-61-1
|
hGCGR Antagonist
|
|
438618-32-7
|
Globo-N-tetraose
|
|
75660-79-6
|
GlcNAcβ(1-4)[Fucα(1-6)]GlcNAc
|
|
108964-40-5
|
GSK 114
|
|
1301761-96-5
|
Geranylgeraniol
|
|
24034-73-9
|
Guanosine 5′-Pyrophosphate Ester 6-Deoxytalose Disodium Salt
|
|
18657-20-0
|
Ganglioside GD2, Disialo, Human Brain
|
|
65988-71-8
|
G2-peptide
|
|
361443-81-4
|
GW2974
|
|
202272-68-2
|
GABAA receptor agent 1
|
|
1571-87-5
|
Geodin hydrate
|
|
3209-10-7
|
GSK-3 Inhibitor XIII
|
|
404828-08-6
|
GSK269962A HCl
|
|
2095432-71-4
|
Gluconic acid sodium salt
|
|
527-07-1
|
3-G1F 2AB (500pmol/vial)
|
|
1107646-30-9
|
GSK J4
|
|
1373423-53-0
|
6-(gamma,gamma-Dimethylallylamino)purine riboside hemihydrate
|
|
33156-15-9
|
GEN-6776
|
|
2009273-71-4
|
GsMTx4 TFA
|
|
1209500-46-8
|
Glycitin 6′′-O-Acetate
|
|
134859-96-4
|
Guanidinium iodide
|
|
19227-70-4
|
Guanosine-1N 5′-monophosphate disodium salt
|
|
1257650-86-4
|
GSK2838232
|
|
1443461-21-9
|
()-Globulol
|
|
489-41-8
|
GlcNAc1-b-6GalNAc-α-PNP
|
|
235752-73-5
|
Glycyrrhizic acid ammonium salt from glycyrrhiza root (licorice)
|
|
53956-04-0
|
Gatifloxacin sesquihydrate
|
|
180200-66-2
|
GM 1489
|
|
170905-75-6
|
Gluconic acid potassium salt
|
|
299-27-4
|
Glycerol 1-Oleyl Ether
|
|
593-31-7
|
Glycogen Phosphorylase Inhibitor inhibitor
|
|
648926-15-2
|
GSK467
|
|
1628332-52-4
|
Goethite
|
|
20344-49-4
|
G-Protein antagonist peptide TFA
|
|
143675-79-0
|
Glutathione Monoethyl Ester
|
|
118421-50-4
|
Gold(I) sodium thiosulfate hydrate
|
|
10210-36-3
|
Ganglioside GD1a disodium salt
|
|
12707-58-3
|
Glycolic acid ethoxylate oleyl ether
|
|
57635-48-0
|
Gold sodium thiomalate
|
|
12244-57-4
|
GRP-60367
|
|
1309241-34-6
|
GBR 13069 dihydrochloride
|
|
77862-93-2
|
6-Geranyl-7-hydroxycoumarin
|
|
148-83-4
|
Guaiene
|
|
88-84-6
|
α-GalNAc-PEG3-Azide
|
|
882873-70-3
|
Grubbs Catalyst M201
|
|
1307233-23-3
|
GLP-1 (9-36) amide TFA
|
|
161748-29-4
|
GSK2200150A
|
|
1443138-53-1
|
Galicaftor (ABBV-2222)
|
|
1918143-53-9
|
Gallic acid monohydrate
|
|
5995-86-8
|
Ganoderic Acid H
|
|
98665-19-1
|
GlcNAcβ(1-2)Man-α-ethylazide
|
|
1858224-15-3
|
Glycine tert-butyl ester dibenzenesulfonimide salt
|
|
77284-30-1
|
Genistein 4′-β-D-Glucuronide
|
|
245084-07-5
|
GSK-3β Inhibitor XI
|
|
626604-39-5
|
Glycidyl palmitate-d5
|
|
1794941-80-2
|
Guanosine 3′,5′-cyclic Monophosphate, b-Phenyl-1,N2-etheno-8-bromo-, Sodium Salt
|
|
144510-04-3
|
Gramicidin TFA
|
|
1405-97-6
|
Garcinoic acid
|
|
91893-83-3
|
Glyceryl trielaidate
|
|
537-39-3
|
G1T38
|
|
1628256-23-4
|
H-Gly-Pro-AMC · HBr
|
|
115035-46-6
|
Glisoxepid
|
|
25046-79-1
|
Glycine 7-amido-4-methylcoumarin hydrobromide
|
|
113728-13-5
|
Ganglioside GQ1b tetrasodium salt
|
|
68652-37-9
|
Globo-H Ceramide
|
|
177475-60-4
|
Glycyl-L-tyrosine Hydrate
|
|
207300-83-2
|
Grindelic acid
|
|
1438-57-9
|
Geranyl monophosphate lithium salt
|
|
16750-99-5
|
Gemcitabine-13C,1N2 Hydrochloride
|
|
1262897-74-4
|
Gibberellin A8
|
|
7044-72-6
|
Guanylin (human) TFA
|
|
183200-12-6
|
Gadolinium silicide
|
|
12134-75-7
|
GlcNPhth[346Ac]β(1-3)Gal[246Bn]-β-MP
|
|
1820575-44-7
|
β-GlcNAc-PEG3-Azide
|
|
86520-54-9
|
6-G1F 2AB (500pmol/vial)
|
|
1107646-29-6
|
Guanosine 5′-triphosphate tris salt
|
|
103192-46-7
|
GR 135531
|
|
190277-13-5
|
GNE-490
|
|
1033739-92-2
|
GSK199
|
|
1549811-53-1
|
GSK-3β Inhibitor VI
|
|
62673-69-2
|
Guanidinium bromide
|
|
19244-98-5
|